Nimodipine nanometer granule and its prepn. method

A nimodipine nanometer and nimodipine technology, which can be used in pharmaceutical formulations, medical preparations of non-active ingredients, cardiovascular system diseases, etc., and can solve problems that have not been reported

Inactive Publication Date: 2007-01-31
张文芳
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The present invention adopts high-pressure emulsification and low-temperature curing method, uses POGC or PEGC as the carrier material, prepares nimodipine nanoparticles, and investigates its physical stability and metabolic behavior in vivo. This work has not been reported at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nimodipine nanometer granule and its prepn. method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Prescription: nimodipine 0.01-1.0g, POGC 0.5-10.0g, glyceryl monostearate 1.0-6.0g, fatty acid 1.0-6.0g, lecithin 2.0-6.0g, mannitol 2.0-10.0g, injection Make up to 30ml with water.

[0030] Preparation method one:

[0031] a) Heating and melting 2.0g of glyceryl monostearate, 1.0g of fatty acid, 1.0g of lecithin, 2.0g of POGC and 1mg of nimodipine, adding the prescribed amount of water for injection (PH10-11) and 5.0g of mannitol and stirring To form colostrum, adjust the pH value to 4.5-7.0, and then use a high-pressure homogenizer to circulate and high-pressure homogenize and emulsify the colostrum system until the particle size meets the requirements.

[0032] b) The above emulsion is filtered, freeze-dried, and filled with a nitrogen pressure cap to obtain the obtained product.

[0033] Preparation method two:

[0034] a) Heat and melt 3.0g glyceryl monostearate, 1.0g fatty acid, 1.0g lecithin, 10.0g POGC and 50mg nimodipine, add prescription water for injection...

Embodiment 2

[0037] Prescription: nimodipine 0.01-1.0g, PEGC 1.0-10.0g, glyceryl monostearate 1.0-6.0g, lecithin 2.0-6.0g, mannitol 2.0-6.0g, add water for injection to 30ml.

[0038] a) Heat and melt 1.0g glyceryl monostearate, 1.0g lecithin, 3.0g PEGC and 0.0005g nimodipine, add prescription water for injection (PH10-11) and 5.0g mannitol and stir to make colostrum , adjust the pH value to 4.5-7.0, and then use a high-pressure homogenizer to circulate and high-pressure homogenize and emulsify the colostrum system until the particle size meets the requirements.

[0039]b) The above emulsion is filtered, freeze-dried, and filled with a nitrogen pressure cap to obtain the obtained product.

Embodiment 3

[0041] Composition: Nimodipine 0.01-1.0g, POGC 1.0-8.0g, glyceryl monolaurate 1.0-6.0g, lecithin 1.0-3.0g, mannitol 2.0-6.0g, low molecular weight dextran 2.0-6.0 g, add water for injection to 100ml.

[0042] Nimodipine 0.005g, POGC 0.5g, glyceryl monolaurate 2.0g and lecithin 1.0g are heated and melted, add 3.0g of mannitol in an appropriate amount of aqueous solution, stir evenly, and stir at high speed until the average particle size of milk droplets is ≤0.5 microns , adding 2.0 g of low-molecular dextran as a freeze-drying protective agent, dissolving and filtering, freeze-drying, and filling a nitrogen pressure cap to obtain the obtained product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A nanoparticle of nimodipine contains nimodipine, the carrier chosen from poloxamer cholesterol ester of fatty acid and cholesterol ester of fatty acid, stabilizer and water. Its preparing process is also disclosed.

Description

technical field [0001] The invention relates to a nimodipine nanoparticle and a preparation method thereof, which is characterized in that it comprises nimodipine, a carrier, a stabilizer and water, wherein the carrier is selected from novel adjuvant fatty acid poloxamer cholesterol ester (PPGC) and fatty acid PEG cholesterol Ester (PEGP), the prepared nanoparticles have a particle size of ≤1um, which has the advantages of high drug loading and good stability. Background technique [0002] The chemical name of Nimodipine is: 1-methylethyl-2-methoxyethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5 - Pyridine dicarboxylates. The molecular weight is 418.45. [0003] Nimodipine is a Ca channel blocker. Normally, the contraction of smooth muscle depends on the entry of Ca into the cell, causing the depolarization of transmembrane currents. Nimodipine achieves the purpose of relieving vasospasm by effectively preventing Ca from entering cells and inhibiting smooth muscle co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K31/435A61K47/34A61K47/24A61P9/10A61P9/08A61K47/28
Inventor 张文芳
Owner 张文芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap